| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 | 1.02e-14 | 363 | 125 | 21 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 | 5.64e-13 | 446 | 125 | 21 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 2.09e-11 | 600 | 125 | 22 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SPHK2 RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 7.98e-11 | 709 | 125 | 23 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | SPHK2 RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 3.46e-10 | 764 | 125 | 23 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SPHK2 RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 OASL MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 3.47e-09 | 938 | 125 | 24 | GO:0016772 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR3 SPHK2 HTR2B MLNR OR6Q1 OR52L1 GPR143 FZD1 FZD8 LHCGR ADGRG7 OR52I2 OR52L2P GPR157 OR4A16 RRH OR1P1 CCR1 TACR2 ADGRA1 TACR3 CNR1 | 2.81e-08 | 884 | 125 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 TSPAN12 GPR3 SPHK2 HTR2B TRPA1 MLNR OR6Q1 OR52L1 GPR143 FCRLA FZD1 FZD8 LHCGR ADGRG7 OR52I2 FCGR1A OR52L2P GPR157 OR4A16 RRH OR1P1 CCR1 TACR2 ADGRA1 TACR3 CNR1 | 6.04e-08 | 1353 | 125 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP13A4 SPNS1 ABCA3 TRPA1 SLC35A1 SLC19A2 SLC28A3 SLC7A6 SLC30A3 SLC5A3 SLC6A2 SLC25A3 SLC35A3 SIDT2 PIEZO2 CLCN4 NALCN ANO6 SLC28A1 KCNN3 KCNQ1 SLC49A3 CNGA3 MCOLN3 MCOLN2 | 6.55e-08 | 1180 | 125 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | NPC1 ATP13A4 SPNS1 ABCA3 TRPA1 SLC35A1 SLC19A2 SLC28A3 SLC7A6 SLC30A3 SLC5A3 SLC6A2 SLC25A3 SLC35A3 SIDT2 PIEZO2 CLCN4 NALCN ANO6 SLC28A1 KCNN3 KCNQ1 SLC49A3 CNGA3 MCOLN3 MCOLN2 | 9.04e-08 | 1289 | 125 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP13A4 TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 PIEZO2 NALCN ANO6 SLC28A1 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 4.02e-06 | 664 | 125 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP13A4 TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 NALCN SLC28A1 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 7.18e-06 | 465 | 125 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP13A4 TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 PIEZO2 CLCN4 NALCN ANO6 SLC28A1 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 9.22e-06 | 793 | 125 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC35A1 SLC28A3 SLC7A6 SLC30A3 SLC5A3 SLC6A2 SLC25A3 SLC35A3 CLCN4 SLC28A1 | 1.74e-05 | 296 | 125 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP13A4 TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 CLCN4 NALCN ANO6 SLC28A1 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 2.09e-05 | 758 | 125 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 3.39e-05 | 59 | 125 | 5 | GO:0015932 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP13A4 TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 NALCN SLC28A1 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 3.88e-05 | 627 | 125 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP13A4 ABCA3 SLC35A1 SLC28A3 SLC7A6 SLC30A3 SLC5A3 SLC6A2 SLC25A3 SLC35A3 CLCN4 SLC28A1 | 4.61e-05 | 477 | 125 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.20e-05 | 33 | 125 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.02e-04 | 171 | 125 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | tachykinin receptor activity | 1.16e-04 | 3 | 125 | 2 | GO:0004995 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.53e-04 | 17 | 125 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.82e-04 | 18 | 125 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 2.31e-04 | 4 | 125 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 2.31e-04 | 4 | 125 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 2.31e-04 | 4 | 125 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.53e-04 | 140 | 125 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.57e-04 | 334 | 125 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.13e-04 | 343 | 125 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 3.84e-04 | 5 | 125 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 5.10e-04 | 59 | 125 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 5.74e-04 | 6 | 125 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | calmodulin binding | 6.20e-04 | 230 | 125 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPA1 PIEZO2 CLCN4 NALCN ANO6 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 6.29e-04 | 459 | 125 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 8.00e-04 | 7 | 125 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 8.00e-04 | 7 | 125 | 2 | GO:0004711 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 9.17e-04 | 119 | 125 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.47e-04 | 31 | 125 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 1.06e-03 | 8 | 125 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.37e-03 | 193 | 125 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.51e-03 | 133 | 125 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.52e-03 | 197 | 125 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.68e-03 | 81 | 125 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.69e-03 | 10 | 125 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 1.69e-03 | 10 | 125 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | channel activity | TRPA1 PIEZO2 CLCN4 NALCN ANO6 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 1.73e-03 | 525 | 125 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPA1 PIEZO2 CLCN4 NALCN ANO6 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 1.75e-03 | 526 | 125 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | antiporter activity | 1.77e-03 | 138 | 125 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.89e-03 | 140 | 125 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 2.06e-03 | 11 | 125 | 2 | GO:0034056 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 2.06e-03 | 11 | 125 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 2.06e-03 | 11 | 125 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.06e-03 | 11 | 125 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | symporter activity | 2.55e-03 | 150 | 125 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.62e-03 | 151 | 125 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 3.37e-03 | 14 | 125 | 2 | GO:1901474 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 3.37e-03 | 14 | 125 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.23e-03 | 52 | 125 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 4.47e-03 | 53 | 125 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 4.65e-03 | 247 | 125 | 6 | GO:0000287 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 4.97e-03 | 17 | 125 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.79e-03 | 182 | 125 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 6.06e-03 | 184 | 125 | 5 | GO:0022832 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | CAMK4 DAPK2 OBSCN TSSK2 DAPK1 DAPK3 STK10 PASK MAP2K2 TSSK4 MVP | 1.23e-07 | 228 | 123 | 11 | GO:0046777 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPR3 SPHK2 HTR2B MLNR OR6Q1 OR52L1 GPR143 ZDHHC7 ADCY6 FZD1 PRKD3 FZD8 LHCGR ADGRG7 OR52I2 OR52L2P GPR157 OR4A16 RRH OR1P1 KCNQ1 CCR1 TACR2 ADGRA1 TACR3 CNR1 | 1.61e-07 | 1395 | 123 | 26 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP13A4 SPHK2 HTR2B TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 LHCGR PIEZO2 NALCN ANO6 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 1.20e-05 | 942 | 123 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP13A4 SPHK2 HTR2B TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 LHCGR PIEZO2 CLCN4 NALCN ANO6 KCNN3 KCNQ1 CCR1 TACR2 CNGA3 MCOLN3 CNR1 MCOLN2 | 1.91e-05 | 1374 | 123 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 2.38e-05 | 96 | 123 | 6 | GO:1901264 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP13A4 SPHK2 HTR2B TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 LHCGR PIEZO2 CLCN4 NALCN ANO6 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 3.31e-05 | 1115 | 123 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP13A4 SPHK2 HTR2B TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 LHCGR CLCN4 NALCN ANO6 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 3.33e-05 | 1017 | 123 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP13A4 SPHK2 HTR2B TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 LHCGR NALCN ANO6 KCNN3 KCNQ1 CNGA3 MCOLN3 MCOLN2 | 3.39e-05 | 922 | 123 | 17 | GO:0098662 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.57e-05 | 208 | 123 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP13A4 SPHK2 HTR2B TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 SLC25A3 LHCGR PIEZO2 NALCN ANO6 KCNN3 KCNQ1 CCR1 CNGA3 MCOLN3 MCOLN2 | 5.45e-05 | 1157 | 123 | 19 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of ceramide biosynthetic process | 7.18e-05 | 14 | 123 | 3 | GO:2000303 | |
| GeneOntologyBiologicalProcess | metal ion transport | ATP13A4 SPHK2 HTR2B TRPA1 SLC28A3 SLC30A3 SLC5A3 SLC6A2 LHCGR NALCN ANO6 KCNN3 KCNQ1 CCR1 CNGA3 MCOLN3 MCOLN2 | 9.23e-05 | 1000 | 123 | 17 | GO:0030001 |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound transmembrane transport | 1.09e-04 | 16 | 123 | 3 | GO:0072531 | |
| GeneOntologyBiologicalProcess | regulation of sphingolipid biosynthetic process | 1.09e-04 | 16 | 123 | 3 | GO:0090153 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | RPS6KA5 CAMK4 RPS6KA1 RPS6KA3 TSSK2 MAP2K2 TSSK1B TSSK4 MGAT5B | 1.27e-04 | 319 | 123 | 9 | GO:0018209 |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.47e-04 | 133 | 123 | 6 | GO:0006939 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | NPC1 GPR3 ATP13A4 TLCD1 SPNS1 ABCA3 HTR2B TRPA1 SLC30A3 ADCY6 LHCGR SIDT2 ORMDL3 ORMDL2 DISP3 KCNQ1 CCR1 VCAM1 CNR1 | 1.49e-04 | 1249 | 123 | 19 | GO:0048878 |
| GeneOntologyBiologicalProcess | calcium ion transport | ATP13A4 SPHK2 HTR2B TRPA1 LHCGR NALCN ANO6 CCR1 CNGA3 MCOLN3 MCOLN2 | 2.38e-04 | 509 | 123 | 11 | GO:0006816 |
| GeneOntologyBiologicalProcess | cellular homeostasis | GPR3 ATP13A4 SPNS1 HTR2B TRPA1 SLC30A3 SLC6A2 LHCGR SIDT2 ORMDL3 ORMDL2 ANO6 KCNQ1 CCR1 VCAM1 CNR1 | 2.41e-04 | 981 | 123 | 16 | GO:0019725 |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.48e-04 | 275 | 123 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | negative regulation of ceramide biosynthetic process | 3.49e-04 | 5 | 123 | 2 | GO:1900060 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 3.61e-04 | 157 | 123 | 6 | GO:0046467 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid metabolic process | 4.32e-04 | 25 | 123 | 3 | GO:1905038 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 4.83e-04 | 61 | 123 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 5.16e-04 | 307 | 123 | 8 | GO:0018105 | |
| GeneOntologyBiologicalProcess | intracellular sphingolipid homeostasis | 5.21e-04 | 6 | 123 | 2 | GO:0090156 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside transport | 5.21e-04 | 6 | 123 | 2 | GO:0015864 | |
| GeneOntologyBiologicalProcess | uridine transmembrane transport | 5.21e-04 | 6 | 123 | 2 | GO:0015862 | |
| GeneOntologyCellularComponent | late endosome membrane | 9.73e-05 | 179 | 124 | 7 | GO:0031902 | |
| GeneOntologyCellularComponent | late endosome | 2.34e-04 | 348 | 124 | 9 | GO:0005770 | |
| GeneOntologyCellularComponent | lysosomal membrane | NPC1 SPNS1 SPHK2 ABCA3 GPR143 SLC30A3 SIDT2 CLCN4 MCOLN3 MCOLN2 | 4.36e-04 | 462 | 124 | 10 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | NPC1 SPNS1 SPHK2 ABCA3 GPR143 SLC30A3 SIDT2 CLCN4 MCOLN3 MCOLN2 | 4.36e-04 | 462 | 124 | 10 | GO:0098852 |
| GeneOntologyCellularComponent | vacuolar membrane | NPC1 SPNS1 SPHK2 ABCA3 GPR143 SLC30A3 SIDT2 CLCN4 MCOLN3 MCOLN2 | 8.92e-04 | 507 | 124 | 10 | GO:0005774 |
| GeneOntologyCellularComponent | serine palmitoyltransferase complex | 9.55e-04 | 8 | 124 | 2 | GO:0017059 | |
| MousePheno | decreased endometrial gland number | 1.18e-05 | 7 | 99 | 3 | MP:0009096 | |
| MousePheno | fused cornea and lens | 2.26e-05 | 24 | 99 | 4 | MP:0001307 | |
| Domain | S_TKc | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 1.05e-15 | 359 | 120 | 22 | SM00220 |
| Domain | Pkinase | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 3.61e-15 | 381 | 120 | 22 | PF00069 |
| Domain | Ser/Thr_kinase_AS | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 | 1.13e-14 | 357 | 120 | 21 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 | 1.49e-14 | 362 | 120 | 21 | PS00108 |
| Domain | Protein_kinase_ATP_BS | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 | 3.68e-14 | 379 | 120 | 21 | IPR017441 |
| Domain | Kinase-like_dom | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MACF1 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 5.41e-13 | 542 | 120 | 23 | IPR011009 |
| Domain | Prot_kinase_dom | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 5.78e-13 | 489 | 120 | 22 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 TRIB1 | 6.80e-13 | 493 | 120 | 22 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | RPS6KA5 KALRN CAMK4 PSKH1 SPEG RPS6KA1 DAPK2 RPS6KA3 OBSCN TSSK2 DAPK1 DAPK3 PAK6 PRKD3 STK10 PASK MAP4K5 MAP2K2 TSSK1B PSKH2 TSSK4 | 1.50e-12 | 459 | 120 | 21 | PS00107 |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.38e-08 | 69 | 120 | 8 | IPR020636 | |
| Domain | DAPK1 | 2.59e-07 | 3 | 120 | 3 | IPR020676 | |
| Domain | Ribosomal_S6_kinase_II | 5.10e-06 | 6 | 120 | 3 | IPR016239 | |
| Domain | ArfGap | 3.40e-05 | 29 | 120 | 4 | SM00105 | |
| Domain | ArfGap | 3.40e-05 | 29 | 120 | 4 | PF01412 | |
| Domain | ARFGAP | 3.40e-05 | 29 | 120 | 4 | PS50115 | |
| Domain | ArfGAP | 3.40e-05 | 29 | 120 | 4 | IPR001164 | |
| Domain | GPCR_2_secretin-like | 4.15e-05 | 60 | 120 | 5 | IPR000832 | |
| Domain | GPCR_2-like | 4.15e-05 | 60 | 120 | 5 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.49e-05 | 61 | 120 | 5 | PS50261 | |
| Domain | 7TM_GPCR_Srsx | 8.52e-05 | 112 | 120 | 6 | SM01381 | |
| Domain | Ion_trans_dom | 9.40e-05 | 114 | 120 | 6 | IPR005821 | |
| Domain | Ion_trans | 9.40e-05 | 114 | 120 | 6 | PF00520 | |
| Domain | GPCR_Rhodpsn_7TM | GPR3 HTR2B MLNR OR6Q1 OR52L1 LHCGR OR52I2 GPR157 OR4A16 RRH CCR1 TACR2 TACR3 CNR1 | 1.02e-04 | 670 | 120 | 14 | IPR017452 |
| Domain | CNT_N_dom | 1.22e-04 | 3 | 120 | 2 | IPR002668 | |
| Domain | Neurokn_rcpt | 1.22e-04 | 3 | 120 | 2 | IPR001681 | |
| Domain | C_nuclsd_transpt | 1.22e-04 | 3 | 120 | 2 | IPR008276 | |
| Domain | ORMDL | 1.22e-04 | 3 | 120 | 2 | PF04061 | |
| Domain | CNT_C_dom | 1.22e-04 | 3 | 120 | 2 | IPR011657 | |
| Domain | C_nuclsd_transpt_met_bac | 1.22e-04 | 3 | 120 | 2 | IPR018270 | |
| Domain | Gate_dom | 1.22e-04 | 3 | 120 | 2 | IPR011642 | |
| Domain | Nucleos_tra2_N | 1.22e-04 | 3 | 120 | 2 | PF01773 | |
| Domain | Oest-rel_rcp | 1.22e-04 | 3 | 120 | 2 | IPR027289 | |
| Domain | ORMDL | 1.22e-04 | 3 | 120 | 2 | IPR007203 | |
| Domain | Nucleos_tra2_C | 1.22e-04 | 3 | 120 | 2 | PF07662 | |
| Domain | Gate | 1.22e-04 | 3 | 120 | 2 | PF07670 | |
| Domain | Nuc_sug_transpt | 4.04e-04 | 5 | 120 | 2 | IPR007271 | |
| Domain | Oest_rcpt/oest-rel_rcp | 4.04e-04 | 5 | 120 | 2 | IPR024178 | |
| Domain | Nuc_sug_transp | 4.04e-04 | 5 | 120 | 2 | PF04142 | |
| Domain | 7tm_1 | GPR3 HTR2B MLNR OR6Q1 OR52L1 LHCGR OR52I2 OR4A16 RRH CCR1 TACR2 TACR3 CNR1 | 4.14e-04 | 677 | 120 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR3 HTR2B MLNR OR6Q1 OR52L1 LHCGR OR52I2 OR4A16 RRH CCR1 TACR2 TACR3 CNR1 | 4.62e-04 | 685 | 120 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR3 HTR2B MLNR OR6Q1 OR52L1 LHCGR OR52I2 OR4A16 RRH CCR1 TACR2 TACR3 CNR1 | 5.02e-04 | 691 | 120 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR3 HTR2B MLNR OR6Q1 OR52L1 LHCGR OR52I2 OR4A16 RRH CCR1 TACR2 TACR3 CNR1 | 5.08e-04 | 692 | 120 | 13 | IPR000276 |
| Domain | ANK_REPEAT | 1.25e-03 | 253 | 120 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.28e-03 | 254 | 120 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.28e-03 | 254 | 120 | 7 | PS50297 | |
| Domain | Ptc/Disp | 1.43e-03 | 9 | 120 | 2 | IPR003392 | |
| Domain | Patched | 1.43e-03 | 9 | 120 | 2 | PF02460 | |
| Domain | Ankyrin_rpt | 1.53e-03 | 262 | 120 | 7 | IPR002110 | |
| Domain | Pkinase_C | 1.71e-03 | 37 | 120 | 3 | IPR017892 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.78e-03 | 10 | 120 | 2 | IPR000003 | |
| Domain | PH | 2.14e-03 | 278 | 120 | 7 | SM00233 | |
| Domain | Frizzled | 2.17e-03 | 11 | 120 | 2 | IPR000539 | |
| Domain | Frizzled | 2.17e-03 | 11 | 120 | 2 | PF01534 | |
| Domain | PKD_channel | 2.17e-03 | 11 | 120 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 2.17e-03 | 11 | 120 | 2 | IPR013122 | |
| Domain | Frizzled | 2.17e-03 | 11 | 120 | 2 | SM01330 | |
| Domain | PH_DOMAIN | 2.18e-03 | 279 | 120 | 7 | PS50003 | |
| Domain | PH_domain | 2.23e-03 | 280 | 120 | 7 | IPR001849 | |
| Domain | Pkinase_C | 2.47e-03 | 42 | 120 | 3 | PF00433 | |
| Domain | SSD | 3.05e-03 | 13 | 120 | 2 | IPR000731 | |
| Domain | SSD | 3.05e-03 | 13 | 120 | 2 | PS50156 | |
| Domain | Ank | 3.57e-03 | 228 | 120 | 6 | PF00023 | |
| Domain | PH | 3.64e-03 | 229 | 120 | 6 | PF00169 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.07e-03 | 50 | 120 | 3 | PS00650 | |
| Domain | 7tm_2 | 4.07e-03 | 50 | 120 | 3 | PF00002 | |
| Domain | Frizzled/SFRP | 4.63e-03 | 16 | 120 | 2 | IPR015526 | |
| Domain | - | 5.36e-03 | 248 | 120 | 6 | 1.25.40.20 | |
| Domain | AGC-kinase_C | 5.60e-03 | 56 | 120 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 5.60e-03 | 56 | 120 | 3 | PS51285 | |
| Domain | S_TK_X | 5.60e-03 | 56 | 120 | 3 | SM00133 | |
| Domain | ANK | 5.67e-03 | 251 | 120 | 6 | SM00248 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ATP13A4 ABCA3 TRPA1 SLC35A1 SLC28A3 SLC7A6 SLC30A3 ADCY6 SLC5A3 SLC6A2 SLC35A3 CLCN4 NALCN ANO6 SLC28A1 MCOLN3 MCOLN2 | 1.69e-06 | 736 | 95 | 18 | M27287 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HTR2B KALRN CAMK4 MLNR RPS6KA1 RPS6KA3 OBSCN GPR143 ADCY6 FZD1 FZD8 LHCGR RRH CCR1 TACR2 TACR3 CNR1 | 3.93e-06 | 702 | 95 | 17 | M746 |
| Pathway | WP_BLADDER_CANCER | 6.82e-06 | 40 | 95 | 5 | M39523 | |
| Pathway | KEGG_BLADDER_CANCER | 8.73e-06 | 42 | 95 | 5 | M19096 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 1.02e-05 | 7 | 95 | 3 | M27096 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 1.02e-05 | 7 | 95 | 3 | MM14784 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ATP13A4 ABCA3 TRPA1 SLC35A1 SLC28A3 SLC7A6 SLC5A3 SLC6A2 SLC35A3 CLCN4 NALCN ANO6 SLC28A1 MCOLN3 MCOLN2 | 1.15e-05 | 681 | 95 | 16 | MM14985 |
| Pathway | WP_GPCRS_NONODORANT | 1.19e-05 | 266 | 95 | 10 | MM15843 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND | 3.44e-05 | 10 | 95 | 3 | M866 | |
| Pathway | WP_GPCRS_OTHER | 4.55e-05 | 96 | 95 | 6 | MM15939 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 5.41e-05 | 99 | 95 | 6 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 7.92e-05 | 106 | 95 | 6 | M27200 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.07e-04 | 217 | 95 | 8 | M18437 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 1.08e-04 | 37 | 95 | 4 | M554 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.58e-04 | 76 | 95 | 5 | MM1433 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.62e-04 | 41 | 95 | 4 | MM15075 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.84e-04 | 176 | 95 | 7 | MM15718 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.95e-04 | 43 | 95 | 4 | M881 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.14e-04 | 81 | 95 | 5 | M13863 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.34e-04 | 183 | 95 | 7 | M997 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 2.66e-04 | 19 | 95 | 3 | MM14780 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 2.68e-04 | 85 | 95 | 5 | M48315 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC35A1 SLC28A3 SLC7A6 SLC30A3 SLC5A3 SLC6A2 SLC35A3 SLC28A1 | 2.74e-04 | 249 | 95 | 8 | M5988 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.77e-04 | 463 | 95 | 11 | M507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 3.52e-04 | 50 | 95 | 4 | M47951 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 3.80e-04 | 330 | 95 | 9 | M18334 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HTR2B KALRN RPS6KA1 RPS6KA3 OBSCN GPR143 ADCY6 LHCGR RRH CCR1 TACR2 TACR3 CNR1 | 3.81e-04 | 646 | 95 | 13 | MM14962 |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 4.16e-04 | 22 | 95 | 3 | M13408 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 4.22e-04 | 144 | 95 | 6 | M39691 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 4.43e-04 | 5 | 95 | 2 | MM15108 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 4.43e-04 | 5 | 95 | 2 | M27277 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 4.43e-04 | 5 | 95 | 2 | MM14977 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 4.49e-04 | 95 | 95 | 5 | M29842 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 5.37e-04 | 210 | 95 | 7 | MM15043 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 6.62e-04 | 6 | 95 | 2 | M47936 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 6.89e-04 | 26 | 95 | 3 | M27434 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 7.53e-04 | 61 | 95 | 4 | M152 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 7.71e-04 | 27 | 95 | 3 | M287 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 7.71e-04 | 27 | 95 | 3 | MM14646 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 7.71e-04 | 27 | 95 | 3 | M45550 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 7.71e-04 | 27 | 95 | 3 | MM14779 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 8.06e-04 | 108 | 95 | 5 | M48078 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 8.51e-04 | 63 | 95 | 4 | MM14714 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 8.60e-04 | 28 | 95 | 3 | MM1391 | |
| Pathway | REACTOME_TRP_CHANNELS | 8.60e-04 | 28 | 95 | 3 | MM14943 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 8.60e-04 | 28 | 95 | 3 | MM15132 | |
| Pathway | REACTOME_TRP_CHANNELS | 8.60e-04 | 28 | 95 | 3 | M27241 | |
| Pathway | REACTOME_RSK_ACTIVATION | 9.23e-04 | 7 | 95 | 2 | M27369 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.12e-03 | 238 | 95 | 7 | MM15076 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 1.16e-03 | 31 | 95 | 3 | M15195 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.20e-03 | 69 | 95 | 4 | M27108 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.26e-03 | 70 | 95 | 4 | MM15959 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.26e-03 | 70 | 95 | 4 | M3115 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.28e-03 | 178 | 95 | 6 | M2890 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 1.57e-03 | 9 | 95 | 2 | M27688 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 1.57e-03 | 9 | 95 | 2 | MM15421 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.60e-03 | 186 | 95 | 6 | MM15994 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.61e-03 | 126 | 95 | 5 | M16763 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.63e-03 | 75 | 95 | 4 | MM14652 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.63e-03 | 75 | 95 | 4 | M39696 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 1.80e-03 | 36 | 95 | 3 | M39908 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.86e-03 | 260 | 95 | 7 | M39397 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 1.95e-03 | 10 | 95 | 2 | M47420 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 1.97e-03 | 132 | 95 | 5 | M39338 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 2.11e-03 | 134 | 95 | 5 | M3574 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 2.11e-03 | 134 | 95 | 5 | M29840 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 2.27e-03 | 82 | 95 | 4 | M27110 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 2.38e-03 | 11 | 95 | 2 | MM15471 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 2.84e-03 | 12 | 95 | 2 | M27728 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 1.98e-08 | 9 | 125 | 4 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 3.28e-08 | 10 | 125 | 4 | 20664521 | |
| Pubmed | The death-associated protein kinases: structure, function, and beyond. | 4.53e-08 | 3 | 125 | 3 | 16756490 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 5.15e-08 | 11 | 125 | 4 | 15381706 | |
| Pubmed | 1.11e-07 | 13 | 125 | 4 | 27713690 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | RPS6KA5 CAMK4 PSKH1 RPS6KA1 RPS6KA3 TSSK2 DAPK3 PAK6 PASK TSSK1B PSKH2 | 1.13e-07 | 372 | 125 | 11 | 22939624 |
| Pubmed | 1.55e-07 | 14 | 125 | 4 | 22453919 | ||
| Pubmed | 3.97e-07 | 78 | 125 | 6 | 17192257 | ||
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 20729278 | ||
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 11297520 | ||
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 23599433 | ||
| Pubmed | Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. | 2.50e-06 | 8 | 125 | 3 | 16223362 | |
| Pubmed | Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. | 3.75e-06 | 9 | 125 | 3 | 17512525 | |
| Pubmed | 5.34e-06 | 10 | 125 | 3 | 29229781 | ||
| Pubmed | NPC1 DPY19L1 GPAT3 ATL3 KLRG2 RER1 ADCY6 SLC35F5 SLC25A3 PRKD3 AP4E1 ORMDL2 ANO6 TMEM131 | 8.86e-06 | 952 | 125 | 14 | 38569033 | |
| Pubmed | Expression of estrogen-related receptors in ovarian cancer and impact on survival. | 1.28e-05 | 2 | 125 | 2 | 34089362 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31116076 | ||
| Pubmed | Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells. | 1.28e-05 | 2 | 125 | 2 | 22160140 | |
| Pubmed | Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2. | 1.28e-05 | 2 | 125 | 2 | 18535204 | |
| Pubmed | ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling. | 1.28e-05 | 2 | 125 | 2 | 33643282 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19716794 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22753890 | ||
| Pubmed | The RSK family of kinases: emerging roles in cellular signalling. | 1.28e-05 | 2 | 125 | 2 | 18813292 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26625210 | ||
| Pubmed | The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. | 1.28e-05 | 2 | 125 | 2 | 16213824 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17494629 | ||
| Pubmed | [Identification of novel metastasis associated genes MAG-1 and MAG-2]. | 1.28e-05 | 2 | 125 | 2 | 21310131 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15185077 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20519530 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12769834 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25889895 | ||
| Pubmed | Differential localization of MAPK-activated protein kinases RSK1 and MSK1 in mouse brain. | 1.28e-05 | 2 | 125 | 2 | 15893597 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 10072763 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19631715 | ||
| Pubmed | Sequence and expression of chicken and mouse rsk: homologs of Xenopus laevis ribosomal S6 kinase. | 1.28e-05 | 2 | 125 | 2 | 2779569 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | SPNS1 TRPA1 RETREG2 ATL3 RER1 ADCY6 SLC5A3 SLC35F5 NUTM1 SIDT2 | 1.38e-05 | 499 | 125 | 10 | 22810586 |
| Pubmed | Entire mitogen activated protein kinase (MAPK) pathway is present in preimplantation mouse embryos. | 1.60e-05 | 14 | 125 | 3 | 15305288 | |
| Pubmed | 1.60e-05 | 14 | 125 | 3 | 9687510 | ||
| Pubmed | Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. | 3.56e-05 | 18 | 125 | 3 | 25117710 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 21501342 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 27455076 | ||
| Pubmed | Evolution of testis-specific kinases TSSK1B and TSSK2 in primates. | 3.84e-05 | 3 | 125 | 2 | 23258646 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 34199599 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19332537 | ||
| Pubmed | p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors. | 3.84e-05 | 3 | 125 | 2 | 36612117 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19036157 | ||
| Pubmed | Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3. | 3.84e-05 | 3 | 125 | 2 | 17453413 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 15226426 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 29888756 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19885840 | ||
| Pubmed | Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. | 3.84e-05 | 3 | 125 | 2 | 12403827 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 18203813 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 15598686 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 12393804 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 11980920 | ||
| Pubmed | Characterization of deoxyribonucleoside transport mediated by concentrative nucleoside transporters. | 3.84e-05 | 3 | 125 | 2 | 33910126 | |
| Pubmed | Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2. | 3.84e-05 | 3 | 125 | 2 | 26158630 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 26977024 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 21868092 | ||
| Pubmed | Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1. | 3.84e-05 | 3 | 125 | 2 | 16606612 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 20736310 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 31086348 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 16595688 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 22855445 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 27063456 | ||
| Pubmed | ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins. | 3.84e-05 | 3 | 125 | 2 | 12093374 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 9651519 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 25332232 | ||
| Pubmed | Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells. | 3.84e-05 | 3 | 125 | 2 | 22031759 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 22041125 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 28082351 | ||
| Pubmed | Simultaneous reduction of all ORMDL proteins decreases the threshold of mast cell activation. | 3.84e-05 | 3 | 125 | 2 | 37316542 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 25395622 | ||
| Pubmed | Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis. | 3.84e-05 | 3 | 125 | 2 | 23066021 | |
| Pubmed | Molecular cloning of the murine substance K and substance P receptor genes. | 3.84e-05 | 3 | 125 | 2 | 1370937 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 28385889 | ||
| Pubmed | Expression of the tachykinin receptor mRNAs in healthy human colon. | 3.84e-05 | 3 | 125 | 2 | 18835556 | |
| Pubmed | Human rsk isoforms: cloning and characterization of tissue-specific expression. | 3.84e-05 | 3 | 125 | 2 | 8141249 | |
| Pubmed | Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex. | 4.94e-05 | 20 | 125 | 3 | 26848828 | |
| Pubmed | 5.75e-05 | 21 | 125 | 3 | 15452121 | ||
| Pubmed | 5.75e-05 | 21 | 125 | 3 | 32301970 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | RER1 DAPK1 STK10 SERPINA1 ORMDL3 CENPI OASL MACF1 HERC2 NUP160 MCOLN3 | 6.01e-05 | 719 | 125 | 11 | 35337019 |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 29920354 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 10781952 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 22303445 | ||
| Pubmed | Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells. | 7.65e-05 | 4 | 125 | 2 | 30479274 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 11507039 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 10629061 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 20182505 | ||
| Pubmed | Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites. | 7.65e-05 | 4 | 125 | 2 | 18239682 | |
| Pubmed | A novel family of serine/threonine kinases participating in spermiogenesis. | 7.65e-05 | 4 | 125 | 2 | 9412477 | |
| Pubmed | Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain. | 7.65e-05 | 4 | 125 | 2 | 11432835 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 25513777 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 22492015 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 26546361 | ||
| Pubmed | TSKS concentrates in spermatid centrioles during flagellogenesis. | 7.65e-05 | 4 | 125 | 2 | 18495105 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 9770464 | ||
| Pubmed | Genomic rearrangements on VCAM1, SELE, APEG1and AIF1 loci in atherosclerosis. | 7.65e-05 | 4 | 125 | 2 | 15784173 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 18039682 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 31880535 | ||
| Interaction | CHRNB2 interactions | 2.91e-06 | 103 | 121 | 7 | int:CHRNB2 | |
| Interaction | TMPRSS12 interactions | 1.00e-05 | 23 | 121 | 4 | int:TMPRSS12 | |
| Interaction | ADGRG5 interactions | 2.06e-05 | 93 | 121 | 6 | int:ADGRG5 | |
| Interaction | UPK1A interactions | 3.42e-05 | 150 | 121 | 7 | int:UPK1A | |
| Cytoband | 1p32-p31 | 2.61e-04 | 9 | 125 | 2 | 1p32-p31 | |
| Cytoband | 15q14 | 3.31e-04 | 49 | 125 | 3 | 15q14 | |
| GeneFamily | Solute carriers | SLC35A1 SLC19A2 SLC28A3 SLC7A6 SLC30A3 SLC5A3 SLC35F5 SLC6A2 SLC25A3 SLC35A3 SLC28A1 SLC49A3 | 5.22e-07 | 395 | 89 | 12 | 752 |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 1.14e-06 | 5 | 89 | 3 | 1021 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 1.85e-05 | 11 | 89 | 3 | 1156 | |
| GeneFamily | ArfGAPs | 2.01e-05 | 33 | 89 | 4 | 395 | |
| GeneFamily | Tachykinin receptors | 7.17e-05 | 3 | 89 | 2 | 258 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 7.46e-05 | 17 | 89 | 3 | 1291 | |
| GeneFamily | Transient receptor potential cation channels | 3.46e-04 | 28 | 89 | 3 | 249 | |
| GeneFamily | 7TM orphan receptors | 3.55e-04 | 6 | 89 | 2 | 310 | |
| GeneFamily | Ankyrin repeat domain containing | 1.24e-03 | 242 | 89 | 6 | 403 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.28e-03 | 11 | 89 | 2 | 286 | |
| GeneFamily | Olfactory receptors, family 52 | 1.80e-03 | 49 | 89 | 3 | 165 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.23e-03 | 161 | 89 | 4 | 593 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.97e-06 | 44 | 123 | 5 | MM485 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP | 4.68e-06 | 199 | 123 | 8 | M7652 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 195 | 124 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.40e-06 | 198 | 124 | 7 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.18e-06 | 81 | 124 | 5 | c9145c994abcf49e5492270b18b0580a3d771ccf | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.18e-06 | 81 | 124 | 5 | 34d2a2c30c749bd2ad447dfb1e43444953d9b154 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.18e-06 | 81 | 124 | 5 | f84bfa55c6b9548f8829b16a145690d207a7bfc1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 177 | 124 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.59e-05 | 191 | 124 | 6 | 2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 192 | 124 | 6 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 192 | 124 | 6 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 192 | 124 | 6 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-05 | 196 | 124 | 6 | 6566e6671257f7df4d3f375e84f0b292ab4bcde1 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.85e-05 | 196 | 124 | 6 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-05 | 197 | 124 | 6 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Tcf7l2_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.94e-05 | 57 | 124 | 4 | eab63d89e2100bb94fb026f700c2f82d657f92c1 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Tcf7l2_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.94e-05 | 57 | 124 | 4 | 2dc04513910af16d2cd84b3ae5b8d4c831124c68 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-05 | 198 | 124 | 6 | e2038d9239e23d670d539f1c58475fd0de028e51 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.07e-05 | 200 | 124 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.07e-05 | 200 | 124 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-05 | 130 | 124 | 5 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.68e-05 | 134 | 124 | 5 | 0b1bb6fee8a2d8c27bca6d9cac6b47e85073dbf7 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.92e-05 | 148 | 124 | 5 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.92e-05 | 148 | 124 | 5 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 6.51e-05 | 151 | 124 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.71e-05 | 152 | 124 | 5 | 18194f757d319958f26e5a91f56d89f25711236f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.36e-05 | 155 | 124 | 5 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.36e-05 | 155 | 124 | 5 | 96c48d835725eac1bc7926f4cddecb67c29b7d7c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.30e-05 | 159 | 124 | 5 | 6115cb03c2ad08e4c1b65893d522f685ff0bc692 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.55e-05 | 160 | 124 | 5 | a90eb621481fd07a821495db07d1032e109fd386 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 166 | 124 | 5 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 166 | 124 | 5 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 166 | 124 | 5 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 166 | 124 | 5 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tnaive/CM_CD8|Liver / Manually curated celltypes from each tissue | 1.27e-04 | 174 | 124 | 5 | 03918ca51ae3b4c9c1a74769b08ea23f518286ba | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 175 | 124 | 5 | 9941c35601134d88d1b3249c81f8b43a8fc61610 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 175 | 124 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.34e-04 | 176 | 124 | 5 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 176 | 124 | 5 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 1.37e-04 | 177 | 124 | 5 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 1.37e-04 | 177 | 124 | 5 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.38e-04 | 94 | 124 | 4 | 4b6623de5a517ebf5df865e0dcd615111622ad3e | |
| ToppCell | PBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 1.41e-04 | 178 | 124 | 5 | 0667abc05eb2254710b9c648c65b7cfdfe7831b7 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.45e-04 | 179 | 124 | 5 | 798f208014f2229c597934775646ddbbacf94b69 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 180 | 124 | 5 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 181 | 124 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.52e-04 | 181 | 124 | 5 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.60e-04 | 183 | 124 | 5 | a6866951866373a1029e04818f4a4a31278c409d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue | 1.60e-04 | 183 | 124 | 5 | beadc69f511cf183e493cb445135f0748ab8b20e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 1.65e-04 | 184 | 124 | 5 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 185 | 124 | 5 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-04 | 185 | 124 | 5 | 0a87d2ee8fffc812224c05a26c729733a5e64d2c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-04 | 185 | 124 | 5 | e63fde030be822ebf32143a41f8cc684cb720f5b | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 1.73e-04 | 186 | 124 | 5 | d7da5edb2ee36f96cdd7e27eb9afcc1cbfd52bb6 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 186 | 124 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 187 | 124 | 5 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 187 | 124 | 5 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 187 | 124 | 5 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.77e-04 | 187 | 124 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.82e-04 | 188 | 124 | 5 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.86e-04 | 189 | 124 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-04 | 190 | 124 | 5 | 4b9bac17eb7ceadada932f2d4a20a5f176088d53 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 191 | 124 | 5 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.96e-04 | 191 | 124 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-04 | 191 | 124 | 5 | 9f0d956e9a14b1cd2c20a52639c6b22c349b377e | |
| ToppCell | 15-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 1.96e-04 | 191 | 124 | 5 | 9359d8c6b00f8977848986baf3c950157adf4c9a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 191 | 124 | 5 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 191 | 124 | 5 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 191 | 124 | 5 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.01e-04 | 192 | 124 | 5 | 5841378789d8267f94071df060debc9171700784 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.01e-04 | 192 | 124 | 5 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.01e-04 | 192 | 124 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 2.01e-04 | 192 | 124 | 5 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 193 | 124 | 5 | 45205ad1ef12aabf33059a7ff922a3bb86994c2f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-04 | 193 | 124 | 5 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 193 | 124 | 5 | 1beca3d3b34082b7d9112fbd094bee8019921ca0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 193 | 124 | 5 | 2ebb950476767f330241b0077ced22e55e124359 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 193 | 124 | 5 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.05e-04 | 193 | 124 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.10e-04 | 194 | 124 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 194 | 124 | 5 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.10e-04 | 194 | 124 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 18-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 2.10e-04 | 194 | 124 | 5 | 9a2efa50731135a178141aae55fa8b3e022c9904 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.10e-04 | 194 | 124 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.15e-04 | 195 | 124 | 5 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Neuronal-GABAergic_neurons|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-04 | 195 | 124 | 5 | efdea22118d5be46c5abfe8e3fbe39503390665d | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.21e-04 | 196 | 124 | 5 | 3408d561d29802fca9eff5c54ccf70818d240cea | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|mLN / Region, Cell class and subclass | 2.21e-04 | 196 | 124 | 5 | 03b79f237e4f7ebab46b277d05377569c6342cf7 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 196 | 124 | 5 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 2.21e-04 | 196 | 124 | 5 | 5a0b5aeff7e535781ea2a4c85799bb468afcb6f8 | |
| ToppCell | mLN-(2)_B_cell-(21)_B_cell_IgG_Plasma|mLN / shred on region, Cell_type, and subtype | 2.21e-04 | 196 | 124 | 5 | e8b12b046d42a58e6f4d9419ab05a5c55e764f34 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 196 | 124 | 5 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.21e-04 | 196 | 124 | 5 | 55a10faafcbe075eefdfcd7cff25ded040c23538 | |
| Computational | Genes in the cancer module 146. | 7.47e-05 | 102 | 75 | 6 | MODULE_146 | |
| Drug | nM-1 | 1.47e-07 | 155 | 121 | 9 | CID000445754 | |
| Drug | ruboxistaurin | 1.69e-06 | 107 | 121 | 7 | CID000153999 | |
| Drug | Goserelin | 2.51e-06 | 41 | 121 | 5 | CID000047725 | |
| Drug | NSC35770 | 4.34e-06 | 80 | 121 | 6 | CID000002800 | |
| Drug | U0125; Down 200; 1uM; PC3; HG-U133A | 1.06e-05 | 197 | 121 | 8 | 663_DN | |
| Disease | cerebral palsy (implicated_via_orthology) | 5.18e-08 | 10 | 119 | 4 | DOID:1969 (implicated_via_orthology) | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.81e-05 | 15 | 119 | 3 | EFO_0004599, EFO_0007892 | |
| Disease | mucolipidosis type IV (implicated_via_orthology) | 4.83e-05 | 3 | 119 | 2 | DOID:0080490 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in large HDL percentage | 7.32e-05 | 55 | 119 | 4 | EFO_0022234 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 9.63e-05 | 4 | 119 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | myristoyl-linoleoyl-glycerol (14:0/18:2) [1] measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800527 | |
| Disease | 1-palmitoleoylglycerol (16:1) measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800398 | |
| Disease | glycoproteinosis (implicated_via_orthology) | 9.63e-05 | 4 | 119 | 2 | DOID:3343 (implicated_via_orthology) | |
| Disease | L lactate dehydrogenase measurement | 1.55e-04 | 26 | 119 | 3 | EFO_0004808 | |
| Disease | body weight | NPC1 RPS6KA5 ESRRG SLC28A3 PAK6 ADCY6 LHCGR EYS MAP4K5 PPIL1 RRH KCNQ1 MGA TRIB1 NUP160 | 1.71e-04 | 1261 | 119 | 15 | EFO_0004338 |
| Disease | glucagon measurement, glucose tolerance test | 2.39e-04 | 6 | 119 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 2.39e-04 | 6 | 119 | 2 | C1834523 | |
| Disease | phospholipids:total lipids ratio | 3.27e-04 | 227 | 119 | 6 | EFO_0020946 | |
| Disease | serum gamma-glutamyl transferase measurement | KALRN RPS6KA3 SLC28A3 FCRLA SLC30A3 SERPINA1 EYS ORMDL3 MAP4K5 OASL KCNN3 TRIB1 | 3.31e-04 | 914 | 119 | 12 | EFO_0004532 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.64e-04 | 150 | 119 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | asthma (implicated_via_orthology) | 3.81e-04 | 35 | 119 | 3 | DOID:2841 (implicated_via_orthology) | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 4.44e-04 | 8 | 119 | 2 | EFO_0802066 | |
| Disease | cholelithiasis | 4.52e-04 | 88 | 119 | 4 | EFO_0004799 | |
| Disease | dyslexia | 5.17e-04 | 162 | 119 | 5 | EFO_0005424 | |
| Disease | Distal arthrogryposis | 5.70e-04 | 9 | 119 | 2 | cv:C0265213 | |
| Disease | hyperlipidemia | 5.70e-04 | 9 | 119 | 2 | MONDO_0021187 | |
| Disease | triglyceride measurement, blood pressure | 5.70e-04 | 9 | 119 | 2 | EFO_0004325, EFO_0004530 | |
| Disease | lifestyle measurement, systolic blood pressure | 5.70e-04 | 9 | 119 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | cholesteryl ester measurement | 6.29e-04 | 257 | 119 | 6 | EFO_0010351 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 6.53e-04 | 97 | 119 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 6.55e-04 | 42 | 119 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | triglycerides in large LDL measurement | 7.02e-04 | 43 | 119 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 7.02e-04 | 43 | 119 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 7.02e-04 | 43 | 119 | 3 | EFO_0022290 | |
| Disease | quinone oxidoreductase-like protein 1 measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0021880 | |
| Disease | cancer (implicated_via_orthology) | 7.82e-04 | 268 | 119 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 8.17e-04 | 103 | 119 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | free androgen index | 8.26e-04 | 374 | 119 | 7 | EFO_0007005 | |
| Disease | 1-stearoyl-GPE (18:0) measurement | 8.66e-04 | 11 | 119 | 2 | EFO_0800227 | |
| Disease | pulmonary emphysema (is_implicated_in) | 8.66e-04 | 11 | 119 | 2 | DOID:9675 (is_implicated_in) | |
| Disease | sphingomyelin measurement | 9.45e-04 | 278 | 119 | 6 | EFO_0010118 | |
| Disease | fetal genotype effect measurement, body weights and measures | 1.03e-03 | 49 | 119 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | Centriacinar Emphysema | 1.04e-03 | 12 | 119 | 2 | C0221227 | |
| Disease | Panacinar Emphysema | 1.04e-03 | 12 | 119 | 2 | C0264393 | |
| Disease | Pathological accumulation of air in tissues | 1.04e-03 | 12 | 119 | 2 | C0013990 | |
| Disease | Focal Emphysema | 1.04e-03 | 12 | 119 | 2 | C2350878 | |
| Disease | tumor protein p53-inducible protein 11 measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0802169 | |
| Disease | inactive gamma-glutamyltranspeptidase 2 measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0801692 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.09e-03 | 50 | 119 | 3 | EFO_0022247 | |
| Disease | aspartate aminotransferase measurement | FLNB KALRN OBSCN FCRLA SLC25A3 SERPINA1 CLCN4 MAP4K5 TRIB1 NUP160 HACD1 | 1.10e-03 | 904 | 119 | 11 | EFO_0004736 |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 1.16e-03 | 51 | 119 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.16e-03 | 51 | 119 | 3 | EFO_0022302 | |
| Disease | C-reactive protein measurement | NPC1 RPS6KA1 SLC30A3 LHCGR CEACAM19 SERPINA1 ORMDL3 OR4A16 MAP4K5 OASL KCNN3 MACF1 TRIB1 | 1.18e-03 | 1206 | 119 | 13 | EFO_0004458 |
| Disease | tRNA (guanine-N(7)-)-methyltransferase measurement | 1.22e-03 | 13 | 119 | 2 | EFO_0802162 | |
| Disease | colitis (implicated_via_orthology) | 1.22e-03 | 13 | 119 | 2 | DOID:0060180 (implicated_via_orthology) | |
| Disease | apolipoprotein E measurement | 1.22e-03 | 13 | 119 | 2 | EFO_0008029 | |
| Disease | N-acetyltaurine measurement | 1.22e-03 | 13 | 119 | 2 | EFO_0020023 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 1.29e-03 | 53 | 119 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 1.29e-03 | 53 | 119 | 3 | EFO_0022258 | |
| Disease | Cocaine-Related Disorders | 1.31e-03 | 117 | 119 | 4 | C0236736 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.37e-03 | 54 | 119 | 3 | EFO_0022244 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | psychosis | 1.42e-03 | 14 | 119 | 2 | EFO_0005407 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | triglycerides in medium VLDL measurement | 1.44e-03 | 55 | 119 | 3 | EFO_0022155 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.49e-03 | 121 | 119 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.49e-03 | 121 | 119 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | triglycerides in large VLDL measurement | 1.52e-03 | 56 | 119 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 1.52e-03 | 56 | 119 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 1.52e-03 | 56 | 119 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.52e-03 | 56 | 119 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 1.52e-03 | 56 | 119 | 3 | EFO_0022251 | |
| Disease | lysophosphatidylcholine 14:0 measurement | 1.64e-03 | 15 | 119 | 2 | EFO_0010356 | |
| Disease | YKL40 measurement | 1.64e-03 | 15 | 119 | 2 | EFO_0004869 | |
| Disease | triglycerides in VLDL measurement | 1.76e-03 | 59 | 119 | 3 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 1.76e-03 | 59 | 119 | 3 | EFO_0022301 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.76e-03 | 59 | 119 | 3 | EFO_0022248 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.76e-03 | 59 | 119 | 3 | EFO_0022289 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.77e-03 | 127 | 119 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Cocaine Abuse | 1.77e-03 | 127 | 119 | 4 | C0009171 | |
| Disease | hypertension (implicated_via_orthology) | 1.83e-03 | 128 | 119 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.85e-03 | 60 | 119 | 3 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 1.85e-03 | 60 | 119 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 1.85e-03 | 60 | 119 | 3 | EFO_0022233 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.85e-03 | 60 | 119 | 3 | EFO_0022237 | |
| Disease | Intrahepatic cholestasis of pregnancy | 1.87e-03 | 16 | 119 | 2 | EFO_0009048 | |
| Disease | infant expressive language ability | 1.87e-03 | 16 | 119 | 2 | EFO_0006316 | |
| Disease | triglycerides in small VLDL measurement | 1.94e-03 | 61 | 119 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.94e-03 | 61 | 119 | 3 | EFO_0022274 | |
| Disease | Seizures | 1.94e-03 | 218 | 119 | 5 | C0036572 | |
| Disease | eye colour measurement | 1.94e-03 | 218 | 119 | 5 | EFO_0009764 | |
| Disease | fatty acid measurement | 1.99e-03 | 436 | 119 | 7 | EFO_0005110 | |
| Disease | triglycerides in small HDL measurement | 2.03e-03 | 62 | 119 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 2.03e-03 | 62 | 119 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 2.03e-03 | 62 | 119 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.03e-03 | 62 | 119 | 3 | EFO_0022339 | |
| Disease | total lipids in very large VLDL measurement | 2.03e-03 | 62 | 119 | 3 | EFO_0022313 | |
| Disease | free cholesterol in very large HDL measurement | 2.03e-03 | 62 | 119 | 3 | EFO_0022273 | |
| Disease | phospholipids in very large VLDL measurement | 2.03e-03 | 62 | 119 | 3 | EFO_0022299 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.10e-03 | 133 | 119 | 4 | EFO_0010092 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.10e-03 | 222 | 119 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Pulmonary Emphysema | 2.11e-03 | 17 | 119 | 2 | C0034067 | |
| Disease | Ulcerative Colitis | 2.13e-03 | 63 | 119 | 3 | C0009324 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.23e-03 | 225 | 119 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | cholesterol in large VLDL measurement | 2.33e-03 | 65 | 119 | 3 | EFO_0021902 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAQLLIWYGVDVMAR | 616 | Q96P64 | |
| LEADMWSIGVITYIL | 196 | P53355 | |
| TTLQMLLEIFVWIGY | 356 | P41595 | |
| LGIVCLVVTIMYWSG | 1216 | Q9P2K9 | |
| VVLAQLLIWYGVDVM | 501 | Q8TF27 | |
| DSMWVVSYVVLGILA | 206 | O43306 | |
| SMIQYVGVLLLYWET | 911 | Q4VNC1 | |
| SWVLLMKYLGNATAI | 261 | P01009 | |
| VGIVLHYSTLSTMLW | 86 | Q86SQ6 | |
| VGLSETMSWLASYLE | 976 | O94983 | |
| LLLDSVLYGLVTWYM | 456 | Q99758 | |
| VGVYTAMWQLALALI | 436 | P51793 | |
| VAVVFGITWILAYLM | 676 | Q96K78 | |
| GITWILAYLMLVNDD | 681 | Q96K78 | |
| LAQLLIWYGVDVMAR | 616 | Q5VW22 | |
| LQVMSWVLGEYSYLL | 511 | Q9UPM8 | |
| WSMGLSLVELAVGRY | 251 | P36507 | |
| QLASEVMLSSVLEWY | 721 | Q68CQ1 | |
| MTTNTYIGLILGAWI | 136 | O14718 | |
| LWLRIFLTDMIIYQG | 446 | Q9NVR2 | |
| WLGYYTQMLLLAAVV | 301 | Q4KMQ2 | |
| VMNSRGIWLAYIILV | 16 | Q53FV1 | |
| MWSLGVTLYTLVFEE | 1186 | Q96RG2 | |
| SLYATEVDIWSLGIM | 576 | Q9NQU5 | |
| MIGTLTALQWFIYDS | 321 | Q00325 | |
| LATGTLFWMEIVLVV | 151 | P51787 | |
| SAVDMWALGVITYAL | 241 | Q96QS6 | |
| IMGYDFLRVLIWLIN | 356 | P22888 | |
| AILASWYALMGAQTI | 1591 | Q5T1H1 | |
| WITGLDSNLKYILVM | 111 | Q8IWI9 | |
| WYIMIIISDILTIIG | 341 | Q8TDD5 | |
| MLLEVTFGKLYAWAV | 1726 | O95714 | |
| MELGLSWVFLVAILE | 1 | P01780 | |
| EVDMWSVGIITYILL | 221 | Q16566 | |
| IWSLGVLLYTMLTGY | 601 | P51812 | |
| LTALALMLGTSLIYW | 201 | Q9BUM1 | |
| MELGLSWVFLVAILE | 1 | P01766 | |
| NSVDMWALGVIAYIL | 276 | P11801 | |
| WALGVIAYILLSGTM | 281 | P11801 | |
| LGEMVQWADILTALY | 311 | Q3V5L5 | |
| LGLVWTLILHYSISM | 111 | O75369 | |
| VVMVIETELSWGLYS | 296 | Q9UGI6 | |
| LIYIVTMVGNLLIWV | 31 | Q8NH70 | |
| TDIWSIGVLTYVMLS | 2861 | O60229 | |
| LEADMWSIGVITYIL | 196 | O43293 | |
| YYASSLVIIWGILAM | 311 | Q2PZI1 | |
| SLDMWSVGVIIYVSL | 756 | O94806 | |
| WSLGVILYTMLSGQV | 606 | O75582 | |
| MVIAVSYGNIVWTLL | 216 | Q8NGQ2 | |
| TRTYVMLALVWGGAL | 151 | P46089 | |
| VIGSTYMLTQDEVLW | 401 | Q14764 | |
| KIALVILESLWSFMG | 1841 | Q9UPN3 | |
| LELLTIYAWEMGTEE | 236 | Q15646 | |
| YVDIMEWLVGTHLAT | 371 | Q86Y26 | |
| TILGLDAMYVIMWIT | 261 | O15118 | |
| WAIGVTAFIMLSAEY | 7851 | Q5VST9 | |
| VWDAAIVLSTYLEMG | 46 | Q8WXB1 | |
| KYLMTLIVGITSGFW | 606 | Q9UP38 | |
| MEWGYLLEVTSLLAA | 1 | Q9H461 | |
| MWLEILLTSVLGFAI | 1 | P07099 | |
| LYWALAFMAVLLAVS | 261 | A4D1S0 | |
| YISLRLTMVWVLGVI | 136 | Q53EU6 | |
| IIWALAILASMPGLY | 156 | P32246 | |
| LEADMWSIGVITYIL | 206 | Q9UIK4 | |
| ALYLSLGVLWVAQML | 11 | Q7L513 | |
| LQSAWMEILILGVVY | 301 | P62508 | |
| LSTILLYHIMAWGLA | 151 | P51810 | |
| LTFYDIAMTAGWLVL | 76 | B0YJ81 | |
| LLTGKLWEMLAYVLL | 171 | Q5UAW9 | |
| IAATLLMADVWFIVA | 491 | Q8IZF7 | |
| LAQLLIWYGVDVMAR | 616 | Q5VUJ5 | |
| ILVLWMLQGSQAALY | 21 | Q7Z692 | |
| IDETYLMFWIGVTSV | 271 | P21554 | |
| MVGLLLIALLTWGYI | 476 | Q6DD88 | |
| YLAVGIMFLVNTVLW | 296 | P12314 | |
| LLLWISGAYGDIVMT | 11 | P06312 | |
| LQSAWMEILILGIVY | 276 | O95718 | |
| LIHYVGWLSTTAMRL | 536 | Q92674 | |
| LSLIVTWFMLLYAQG | 106 | O60779 | |
| WGEMTLSLFSLLIAA | 361 | O60779 | |
| MIGLVTSLSESWYNL | 1036 | Q16531 | |
| WYVLVIISDLMTIIG | 346 | Q8IZK6 | |
| AVMFVAYSVIGLTLW | 211 | P21452 | |
| WLYVINNTLMSLSVG | 556 | Q9Y4K4 | |
| QLGALRVMLWVTTAY | 241 | O43193 | |
| VMNSRGIWLSYVLAI | 16 | Q8N138 | |
| LWMYVVTVAGNLLIV | 46 | Q8NH06 | |
| WLAISLSAMYIIALL | 56 | Q8NH67 | |
| ALVGNVTILFIIWMD | 56 | Q8NGH7 | |
| ALVGNVTILFIIWMD | 56 | Q8NGH6 | |
| LLVTVLWTLLVYSML | 341 | Q92521 | |
| LMVVVIVLYFSLWKG | 241 | P23975 | |
| LWVRNIQMYLSGIIV | 206 | P78382 | |
| AVRWVVTLGLSFVYM | 41 | O15258 | |
| VVILGASNILWIMFA | 6 | P19320 | |
| LLVMGNVINWSLAAY | 691 | Q8NBJ9 | |
| IWSLAGAMLYAVYIV | 331 | Q8WV83 | |
| QMEIWGVYTLLTTHL | 341 | Q8N6T0 | |
| GIMISYIVLLSILLW | 206 | Q8NC44 | |
| WNLYVSVILLIGMTA | 156 | P53794 | |
| WGILLAGYLVMVISA | 106 | Q9HAS3 | |
| LIMGITYTIVGITLW | 261 | P29371 | |
| EMITAITSYLLQLLW | 856 | Q12769 | |
| VFMILLIIVYWDSAG | 16 | Q9NRB3 | |
| MLWLVLDYSADVLYV | 201 | Q16281 | |
| LVLSMEQINWLSLVY | 61 | Q6UXD7 | |
| GLLIATLMWFISNKY | 126 | Q53HI1 | |
| DTWSMGVILYTLVVA | 221 | Q6SA08 | |
| MDISNVLEWIIYTTG | 801 | O75762 | |
| DVWSLGVMLYTLLVG | 266 | Q96RU8 | |
| WVTLEGDFVLMLAIS | 531 | Q9NRA0 | |
| ATDIWGAGVLTYIML | 3141 | Q15772 | |
| LETSMGIIVLELYWK | 16 | Q9Y3C6 | |
| SMNWAIVADILLYVV | 396 | Q9H2V7 | |
| YKADIWSLGITLIEM | 216 | O94804 | |
| WELALYIIISGIMSA | 1116 | Q92545 | |
| LLVMYYTLATLIRIW | 341 | Q9H5I5 | |
| LAMILTITLLWALYY | 236 | O95859 | |
| VISVLYHVGLMQWVI | 276 | O00337 | |
| DMLVEIETAWSLSGY | 71 | Q96CP7 | |
| VSLWMVTGILLYLAF | 151 | Q99726 | |
| LVHTASYGMSLIVWA | 71 | Q92536 | |
| VYDIWSLGVILYIMV | 196 | Q9BXA7 | |
| AVMTWLLVAYADFVV | 51 | Q9NXF8 | |
| LGVYQWLSLVILMTG | 136 | Q9Y2D2 | |
| AGILFSLVVMLYVIW | 156 | Q6ZP80 | |
| VYDIWSLGVILYIMV | 196 | Q96PF2 | |
| DIWSLGILLYTMLAG | 596 | Q15418 | |
| LLGLVTYLDWVMIIV | 881 | Q8IZF0 |